Boston Scientific unit faces charges over defibrillators

02/25/2010 | Star Tribune (Minneapolis-St. Paul, Minn.)

The Department of Justice on Thursday accused Guidant, a Boston Scientific unit, of not informing the FDA of failures in three models of implantable defibrillators, which have been linked to at least seven deaths. A spokesman for Boston Scientific said, "We continue to believe that Guidant and its employees acted in good faith and with the intention of complying with applicable laws and regulations."

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL